QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.105213v1 318/3/1330    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, C. Articles by Gonzalez, F. J. Search for Related Content PubMed PubMed Citation Articles by Chen, C. Articles by Gonzalez, F. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Urinary Metabolite Profiling Reveals CYP1A2-Mediated Metabolism of NSC686288 (Aminoflavone)

Laboratories of Metabolism (C.C., X.M., K.W.K., F.J.G.) and Molecular Pharmacology (L.M., Y.P.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic (J.R.I.)

NSC686288 [aminoflavone (AF)], a candidate chemotherapeutic agent, possesses a unique antiproliferative profile against tumor cells. Metabolic bioactivation of AF by drug-metabolizing enzymes, especially CYP1A monooxygenases, has been implicated as an underlying mechanism for its selective cytotoxicity in several cell culture-based studies. However, in vivo metabolism of AF has not been investigated in detail. In this study, the structural identities of 13 AF metabolites (12 of which are novel) in mouse urine or from microsomal incubations, including three monohydroxy-AFs, two dihydroxy-AFs and their sulfate and glucuronide conjugates, as well as one N-glucuronide, were determined by accurate mass measurements and liquid chromatography-tandem mass spectrometry fragmentation patterns, and a comprehensive map of the AF metabolic pathways was constructed. Significant differences between wild-type and Cyp1a2-null mice, within the relative composition of urinary metabolites of AF, demonstrated that CYP1A2-mediated regioselective oxidation was a major contributor to the metabolism of AF. Comparisons between wild-type and CYP1A2-humanized mice further revealed interspecies differences in CYP1A2-mediated catalytic activity. Incubation of AF with liver microsomes from all three mouse lines and with pooled human liver microsomes confirmed the observations from urinary metabolite profiling. Results from enzyme kinetic analysis further indicated that in addition to CYP1A P450s, CYP2C P450s may also play some role in the metabolism of AF.

Address correspondence to: Dr. Frank J. Gonzalez, Laboratory of Metabolism, National Cancer Institute, 37 Convent Drive, Bethesda, MD 20892. E-mail: fjgonz{at}helix.nih.gov

This article has been cited by other articles:

				L.-h. Meng, Z. Meng, Z.-h. Miao, T. D. Veenstra, and Y. Pommier Cytokeratin-RNA Cross-Linking Mediated by the Antitumor Aminoflavone, 5-Amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 674 - 680. [Abstract] [Full Text] [PDF]

				X. Ma, C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez A Metabolomic Perspective of Melatonin Metabolism in the Mouse Endocrinology, April 1, 2008; 149(4): 1869 - 1879. [Abstract] [Full Text] [PDF]

				C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice J. Biol. Chem., February 22, 2008; 283(8): 4543 - 4559. [Abstract] [Full Text] [PDF]

				F. J. Gonzalez CYP2E1 Drug Metab. Dispos., January 1, 2007; 35(1): 1 - 8. [Abstract] [Full Text] [PDF]